Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
St. Jude Medical
MedTech
FDA approves Abbott's latest Amplatzer Talisman heart implant
The Talisman device builds off the company’s previous Amplatzer occluder for treating a patent foramen ovale, a gap between the left and right atria.
Conor Hale
Oct 4, 2021 9:50am
Epic success: FDA OKs Abbott's newest replacement mitral valve
Sep 22, 2021 3:20pm
St. Jude Medical, Alere settle DOJ false claims allegations
Jul 9, 2021 10:20am
Procyrion bags $30M to push heart failure pump through the clinic
Jul 10, 2019 7:10am
Otsuka inks ReCor buyout to enter renal denervation field
Jul 10, 2018 10:04am
Abbott rolls out smartphone-connected ICM in the U.S.
Oct 23, 2017 12:05pm
